(66)Ga: A Novelty or a Valuable Preclinical Screening Tool for the Design of Targeted Radiopharmaceuticals?

Emerging interest in extending the plasma half-life of small molecule radioligands warrants a consideration of the appropriate radionuclide for PET imaging at longer time points (>8 h). Among candidate positron-emitting radionuclides, (66)Ga (t(1/2) = 9.5 h, β+ = 57%) has suitable nuclear and che...

Descripción completa

Detalles Bibliográficos
Autores principales: Amor-Coarasa, Alejandro, Kelly, James M., Ponnala, Shashikanth, Nikolopoulou, Anastasia, Williams, Clarence, Babich, John W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222850/
https://www.ncbi.nlm.nih.gov/pubmed/30304795
http://dx.doi.org/10.3390/molecules23102575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222850/
https://www.ncbi.nlm.nih.gov/pubmed/30304795
http://dx.doi.org/10.3390/molecules23102575

Ejemplares similares